GLP-1 drugs may curb atrial fibrillation
Reuters: Varun Sundaram, associate professor of medicine, commented on how the study was not designed to prove the GLP-1 drugs caused the reduction in atrial fibrillation (AF) events. “Given the growing obesity epidemic and the rising prevalence of atrial fibrillation,” it lays the foundation for a new approach to treating AF if larger trials confirm the potential benefits, said Sundaram.